错误折叠的α同核素与阿尔茨海默氏症蛋白质病变的同时发生
medRxiv : the preprint server for health sciences
|October 17, 2024
概括
错误折叠的α-synuclein (syn) 种子在患有阿尔茨海默氏症 (AD) 风险的人群中被检测到. 同核素的阳性与阿尔茨海默病生物标志物和更快的认知衰退相关,这表明它在痴呆症进展中的作用.
科学领域:
- 神经科学是一个神经科学.
- 生物标志物发现发现
- 痴呆症研究 痴呆症研究
背景情况:
- 多种病因痴呆症需要体内标志物用于共同病理,例如错误折叠的α-synuclein (syn).
- 种子放大试验 (SAA) 提供了一种检测syn聚合物 (syn种子) 的方法.
- 在阿尔茨海默氏症 (AD) 风险队列中研究同位症病理是至关重要的.
研究的目的:
- 使用同核素种子放大试验 (synSAA) 测量错误折叠的合成聚合物 (syn-seeds).
- 为了检查合成种子和阿尔茨海默病 (AD) 生物标志物之间的关系.
- 评估合成种子与AD风险队列的认知衰退的关联.
主要方法:
- 分析了AD风险队列中的420名参与者的脑脊液 (CSF).
- 进行了同核素种子放大试验 (synSAA).
- 结果与酸化 (T),β-粉样蛋白 (A) 水平和纵向认知结果进行了比较.
主要成果:
- 同核素阳性 (synSAA+) 与酸化 (T) (36%对20%,p=0.011) 有关.
- 与synSAA-个人 (p=0.00050) 相比,SynSAA+个体的认知障碍 (10%的MCI,10%的痴呆症) 的患病率更高.
- 在synSAA+参与者的认知表现在数字符号测试中下降了大约40%的速度.
结论:
- 在阿尔茨海默病 (AD) 风险队列中,普遍的α-synuclein (syn) 共同病理得到了支持.
- 同核素种子可能表明增加的风险或共同病理的存在,有助于认知能力下降.
- 需要进一步的研究来了解综合病理和疾病进展之间的关系.
更多相关视频
09:27Sequential Extraction of Soluble and Insoluble Alpha-Synuclein from Parkinsonian Brains
Published on: January 5, 2016
17.2K
12:01Detection of Disease-associated α-synuclein by Enhanced ELISA in the Brain of Transgenic Mice Overexpressing Human A53T Mutated α-synuclein
Published on: May 30, 2015
10.7K
相关概念视频
Amyloid Fibrils
9.3K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.3K
Alzheimer's Disease: Overview
449
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
449
Neural Regulation
39.1K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.1K
